Skip to main content
. 2015 Apr 12;15:31. doi: 10.1186/s12894-015-0022-9

Table 1.

Baseline characteristics

Tadalafil OaD (N = 139) Tadalafil PRN (N = 143) a Placebo (N = 141) Overall (N = 423) a
Age, years
 Mean (SD) 58.6 (5.07) 57.5 (5.91) 57.6 (5.69) 57.9 (5.58)
 <61 years, n (%) 82 (59.0) 85(59.4) 91 (64.5) 258 (61.0)
 61-68 years, n (%) 57 (41.0) 58 (40.6) 50 (35.5) 165 (39.0)
nsRP approach, n (%)
 Open surgery 68 (48.9) 65 (45.5) 56 (39.7) 189 (44.7)
 Conventional laparoscopy 29 (20.9) 31 (21.7) 28 (19.9) 88 (20.9)
 Robot-assisted laparoscopy 31 (22.3) 41 (28.7) 44 (31.2) 116 (27.4)
 Other 11 (7.9) 6 (4.2) 13 (9.2) 30 (7.1)
IIEF-EF at randomization (V4, after prostatectomy)
 N with data 137 140 137 414
 Mean (SD) 6.0 (5.80) 6.7 (5.57) 6.5 (6.08) 6.4 (5.81)
EPIC sexual domain score
 N with data 133 140 137 410
 Mean (SD) 19.8 (19.56) 21.9 (20.16) 20.1 (21.87) 20.6 (20.53)
EPIC urinary incontinence domain score
 N with data 133 139 137 409
 Mean (SD) 46.7 (30.71) 47.9 (28.89) 49.5 (28.05) 48.0 (29.17)
EPIC urinary irritative/obstructive domain score
 N with data 131 137 134 402
 Mean (SD) 78.1 (18.92) 81.5 (15.08) 81.3 (16.42) 80.4 (16.88)
EPIC bowel domain total score
 N with data 129 134 136 399
 Mean (SD) 88.3 (15.32) 91.2 (10.31) 89.9 (13.69) 89.8 (13.27)
EPIC hormonal domain score
 N with data 130 137 136 403
 Mean (SD) 90.0 (12.71) 92.0 (10.51) 91.4 (10.89) 91.2 (11.39)

aData presented for all patients randomized. One patient assigned to tadalafil PRN did not receive any study drug and was therefore not included in the ITT population.

Abbreviations: EPIC Expanded Prostate Cancer Index Composite (EPIC-26), IIEF-EF International Index of Erectile Function – Erectile Function, ITT intent-to-treat, N number of patients, n number of patients with characteristic, nsRP bilateral nerve-sparing prostatectomy, NSS Nelson Nerve-Sparing score, OaD once daily, PRN “pro-re-nata”/on-demand, SD standard deviation, V visit EPIC scores range from 0–100, higher scores indicate better values.